| Year |
Citation |
Score |
| 2018 |
Ting PY, Parker AE, Lee JS, Trussell C, Sharif O, Luna F, Federe G, Barnes SW, Walker JR, Vance J, Gao MY, Klock HE, Clarkson S, Russ C, Miraglia LJ, ... ... Snead JL, et al. Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells. Nature Methods. PMID 30297964 DOI: 10.1038/S41592-018-0149-1 |
0.323 |
|
| 2017 |
Yu VWC, Liu Y, Curran M, Zhang P, Snead J, Schmedt C, Yang Y, Lin VG, Tschantz WR, Quinn L, Russ C, Clarkson S, Janiak A, Stewart M, Mulumba Y, et al. CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell Disease Blood. 130: 535-535. DOI: 10.1182/Blood.V130.Suppl_1.535.535 |
0.389 |
|
| 2012 |
Boitano AE, de Lichtervelde L, Snead JL, Cooke MP, Schultz PG. An image-based screen identifies a small molecule regulator of megakaryopoiesis. Proceedings of the National Academy of Sciences of the United States of America. 109: 14019-23. PMID 22891346 DOI: 10.1073/Pnas.1212545109 |
0.398 |
|
| 2012 |
Traer E, MacKenzie R, Snead J, Agarwal A, Eiring AM, O'Hare T, Druker BJ, Deininger MW. Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors Leukemia. 26: 1140-1143. PMID 22094585 DOI: 10.1038/Leu.2011.325 |
0.384 |
|
| 2010 |
Traer E, MacKenzie R, Snead J, Druker BJ, Deininger MW. JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo Blood. 116: 199-199. DOI: 10.1182/Blood.V116.21.199.199 |
0.407 |
|
| 2009 |
Snead JL, O'Hare T, Adrian LT, Eide CA, Lange T, Druker BJ, Deininger MW. Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosis. Blood. 114: 3459-63. PMID 19706883 DOI: 10.1182/Blood-2007-10-113969 |
0.366 |
|
| 2009 |
Mackenzie R, Snead J, VanDyke J, Deininger M. Defining Extrinsic Survival Pathways in CML Progenitor Cells. Blood. 114: 941-941. DOI: 10.1182/Blood.V114.22.941.941 |
0.46 |
|
| 2009 |
McWeeney S, Yochum G, Pemberton LC, Loriaux M, Vartanian K, Willis SG, Wilmot B, Turpaz Y, Pillai R, partlin MM, Snead J, Druker BJ, O'Brien SG, Melo JV, Lange T, et al. A Gene Expression Signature of CD34+ Cells to Predict Major Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib: Potential Involvement of Beta-Catenin in Drug Resistance. Blood. 114: 508-508. DOI: 10.1182/Blood.V114.22.508.508 |
0.314 |
|
| 2008 |
Snead JL, O'Hare T, Eide CA, Deininger MW. New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided? Clinical Lymphoma & Myeloma. 8: S107-17. PMID 19254881 DOI: 10.3816/CLM.2008.s.006 |
0.343 |
|
| 2007 |
Snead JL, Sullivan M, Lowery DM, Cohen MS, Zhang C, Randle DH, Taunton J, Yaffe MB, Morgan DO, Shokat KM. A coupled chemical-genetic and bioinformatic approach to Polo-like kinase pathway exploration. Chemistry & Biology. 14: 1261-72. PMID 18022565 DOI: 10.1016/J.Chembiol.2007.09.011 |
0.358 |
|
| Show low-probability matches. |